Safe staffing for nursing in adult inpatient wards in acute hospitals – NICE Guidance SG1 – July 2014

Posted on July 22, 2014. Filed under: Nursing, Workforce | Tags: |

Safe staffing for nursing in adult inpatient wards in acute hospitals – NICE Guidance SG1 – July 2014

NICE unveils safe staffing plans for nursing care in wards – 15 July 2014

Safe staffing for nursing in adult inpatient wards in acute hospitals overview – Pathways

Advertisements
Read Full Post | Make a Comment ( Comments Off on Safe staffing for nursing in adult inpatient wards in acute hospitals – NICE Guidance SG1 – July 2014 )

Service user experience in adult mental health – NICE Evidence Update – June 2014

Posted on June 5, 2014. Filed under: Mental Health Psychi Psychol | Tags: |

Service user experience in adult mental health – NICE Evidence Update – June 2014

A summary of selected new evidence relevant to NICE clinical guideline 136 ‘Service user experience in adult mental health: improving the experience of care for people using adult mental health services’ (2011)

Read Full Post | Make a Comment ( Comments Off on Service user experience in adult mental health – NICE Evidence Update – June 2014 )

Infection prevention and control (QS61) – NICE Quality Standard – April 2014

Posted on April 17, 2014. Filed under: Infection Control | Tags: |

Infection prevention and control (QS61) – NICE Quality Standard – April 2014

News release: “NHS must renew hygiene efforts to tackle “unacceptable and avoidable” infection rates” – 17 April 2014

Extract:

“This latest NICE quality standard contains six statements designed to reduce infection rates, including a statement recommending that patients should be looked after by healthcare workers who always clean their hands thoroughly, both immediately before and immediately after contact or care.

The quality standard also aims to tackle the growing threat of antibiotic resistance by recommending that antibiotics be prescribed only in accordance with local antibiotic formularies – as part of a system to stem resistance of infections to antibiotics.”

… continues on the site

 

Read Full Post | Make a Comment ( Comments Off on Infection prevention and control (QS61) – NICE Quality Standard – April 2014 )

Alcohol-use disorders: preventing harmful drinking – NICE Evidence Update March 2014

Posted on March 5, 2014. Filed under: Alcohol & Drug Dep., Preventive Healthcare | Tags: |

Alcohol-use disorders: preventing harmful drinking – NICE Evidence Update March 2014

A summary of selected new evidence relevant to NICE public health guidance 24 ‘Alcohol-use disorders: preventing harmful drinking’ (2010)

Read Full Post | Make a Comment ( Comments Off on Alcohol-use disorders: preventing harmful drinking – NICE Evidence Update March 2014 )

The influence of cost-effectiveness and other factors on NICE decisions – Centre for Health Economics, University of York – November 2013

Posted on December 10, 2013. Filed under: Evidence Based Practice, Health Economics, Health Mgmt Policy Planning, Health Policy | Tags: , |

The influence of cost-effectiveness and other factors on NICE decisions – Centre for Health Economics, University of York – November 2013

“Abstract

Background: The National Institute for Health and Care Excellence (NICE) emphasises that costeffectiveness is not the only consideration in health technology appraisal and is increasingly explicit about other factors considered relevant. Observing NICE decisions and the evidence considered in each appraisal allows us to ‘reveal’ its implicit weights.

Objectives: This study aims to investigate the influence of cost-effectiveness and other factors on NICE decisions and to investigate whether NICE’s decision-making has changed through time.

Methods: We build on and extend the modelling approaches in Devlin and Parkin (2004) and Dakin et al (2006). We model NICE’s decisions as binary choices: i.e. recommendations for or against use of a healthcare technology in a specific patient group. Independent variables comprised: the clinical and economic evidence regarding that technology; the characteristics of the patients, disease or treatment; and contextual factors affecting the conduct of health technology appraisal. Data on all NICE decisions published by December 2011 were obtained from HTAinSite [www.htainsite.com].

Results: Cost-effectiveness alone correctly predicted 82% of decisions; few other variables were significant and alternative model specifications led to very small variations in model performance. The odds of a positive NICE recommendation differed significantly between musculoskeletal disease, respiratory disease, cancer and other conditions. The accuracy with which the model predicted NICE recommendations was slightly improved by allowing for end of life criteria, uncertainty, publication date, clinical evidence, only treatment, paediatric population, patient group evidence, appraisal process, orphan status, innovation and use of probabilistic sensitivity analysis, although these variables were not statistically significant. Although there was a non-significant trend towards more recent decisions having a higher chance of a positive recommendation, there is currently no evidence that the threshold has changed over time. The model with highest prediction accuracy suggested that a technology costing £40,000 per quality-adjusted life-year (QALY) would have a 50% chance of NICE rejection (75% at £52,000/QALY; 25% at £27,000/QALY).

Discussion: Past NICE decisions appear to have been based on a higher threshold than the £20,000 – £30,000/QALY range that is explicitly stated. However, this finding may reflect consideration of other factors that drive a small number of NICE decisions or cannot be easily quantified.”

Read Full Post | Make a Comment ( Comments Off on The influence of cost-effectiveness and other factors on NICE decisions – Centre for Health Economics, University of York – November 2013 )

Developing and updating local formularies: NICE good practice guidance – NICE – 14 December 2012

Posted on January 4, 2013. Filed under: Pharmacy | Tags: |

Developing and updating local formularies: NICE good practice guidance – NICE – 14 December 2012

“The purpose of this guidance is to provide good practice recommendations for the systems and processes needed to ensure NHS organisations develop and update local formularies effectively and in accordance with statutory requirements. This guidance is for people involved in handling, prescribing and commissioning medicines within the NHS, to support the development of local formularies that reflect local needs, reduce variation in prescribing, and allow rapid uptake of innovative medicines and treatments.”

… continues

Press release

Read Full Post | Make a Comment ( Comments Off on Developing and updating local formularies: NICE good practice guidance – NICE – 14 December 2012 )

Bridging the gap: Why some people are not offered the medicines that NICE recommends – IMS Health – November 2012

Posted on December 4, 2012. Filed under: Evidence Based Practice, Pharmacy | Tags: , |

Bridging the gap: Why some people are not offered the medicines that NICE recommends – IMS Health – November 2012

by Peter Stephens

Extract from the Executive Summary:

“The extent of variation in the uptake of NICE recommended medicines across the NHS in England has been described before. The reasons for such variations are less well understood.

With the encouragement of the Metrics Oversight Group, a joint Department of Health, Industry and NHS group, IMS Health conducted a qualitative study during the summer and autumn of 2012 to help investigate the reasons for that variation.”

Read Full Post | Make a Comment ( Comments Off on Bridging the gap: Why some people are not offered the medicines that NICE recommends – IMS Health – November 2012 )

Hip fracture for adults quality standard – NICE – 27 March 2012

Posted on March 30, 2012. Filed under: Clin Governance / Risk Mgmt / Quality, Orthopaedics | Tags: |

Hip fracture for adults quality standard – NICE – 27 March 2012

About this

Read Full Post | Make a Comment ( Comments Off on Hip fracture for adults quality standard – NICE – 27 March 2012 )

Infection: prevention and control of healthcare-associated infections in primary and community care – NICE – 28 March 2012

Posted on March 28, 2012. Filed under: Infection Control | Tags: , |

Infection: prevention and control of healthcare-associated infections in primary and community care – NICE – 28 March 2012

Clinical guidelines, CG139 – Issued: March 2012

“This clinical guideline (published March 2012) updates and replaces NICE clinical guideline 2 (published June 2003). It offers evidence-based advice on the prevention and control of healthcare-associated infections in primary and community care. New and updated recommendations address areas in which clinical practice for preventing healthcare-associated infections in primary and community care has changed, where the risk of healthcare-associated infections is greatest, and where the evidence has changed.”

Read Full Post | Make a Comment ( Comments Off on Infection: prevention and control of healthcare-associated infections in primary and community care – NICE – 28 March 2012 )

Here’s a really NICE app – 21 March 2012

Posted on March 21, 2012. Filed under: Clin Governance / Risk Mgmt / Quality, Health Informatics | Tags: , |

Here’s a really NICE app – 21 March 2012

Chris Thorne

“A nice NICE app

The National Institute for Health and Clinical Excellence has created an app to give healthcare professionals “quick and easy” access to its recommendations and guidance.

The free app, called NICE Guidance, is available to download now for users of Android and iPhone smartphones, and features more than 760 guidelines, including information on hypertension and stroke.

Jane Gizbert, communications director at NICE said: “For the first time, doctors, nurses and other users of NICE guidance will be able to access recommendations wherever they are.

“The app will provide offline access to all guidance products, including clinical guidelines, public health guidance, technology appraisals, interventional procedures guidance, medical technology and diagnostics guidance.”

NICE is an independent organisation responsible for evaluating drugs and other health interventions. It provides national guidance and standards on the promotion of good health and the prevention and treatment of ill health.

The organisation said it had developed the app in response to demand from clinicians and other users of its guidance.

Guidelines are arranged by clinical or public health topic, and the app will be automatically updated when it is open and access to the internet is available, so that new guidance and changes are incorporated.

Users can bookmark sections for easy access, and email sections to themselves and colleagues. Users can also adjust font size to make it easier to read.

“This is the first in a series of proposed app developments from NICE, which will eventually cover medicines and prescribing information, NICE Pathways and other NICE products,” said Gizbert.

The app works on Android Smartphones, Apple iPhones and iPod touches running iOS 4.3 and above. Users have been able to download the app from Apple’s iStore and the Android market since yesterday (20 March).”

Read Full Post | Make a Comment ( Comments Off on Here’s a really NICE app – 21 March 2012 )

Patient experience in adult NHS services quality standard – NICE – 29 February 2012

Posted on February 29, 2012. Filed under: Clin Governance / Risk Mgmt / Quality, Patient Participation | Tags: |

Patient experience in adult NHS services quality standard – NICE – 29 February 2012

“1 Patients are treated with dignity, kindness, compassion, courtesy, respect, understanding and honesty.
2 Patients experience effective interactions with staff who have demonstrated competency in relevant communication skills.
3 Patients are introduced to all healthcare professionals involved in their care, and are made aware of the roles and responsibilities of the members of the healthcare team.
4 Patients have opportunities to discuss their health beliefs, concerns and preferences to inform their individualised care.
5 Patients are supported by healthcare professionals to understand relevant treatment options, including benefits, risks and potential consequences.”

… continues on the site

Read Full Post | Make a Comment ( Comments Off on Patient experience in adult NHS services quality standard – NICE – 29 February 2012 )

Service user experience in adult mental health – NICE Guideline [UK] – 14 December 2011

Posted on December 16, 2011. Filed under: Mental Health Psychi Psychol | Tags: , |

Service user experience in adult mental health – NICE Guideline [UK] – 14 December 2011

“This clinical guidance offers evidence-based advice on ensuring a good experience of care for people who use adult NHS mental health services.

We have also published a quality standard describing high-quality care for adults using mental health services in the NHS in England.”

Quality standard for service user experience in adult mental health – NICE

Read Full Post | Make a Comment ( Comments Off on Service user experience in adult mental health – NICE Guideline [UK] – 14 December 2011 )

NICE publishes new end of life care quality standard – 30 November 2011

Posted on December 9, 2011. Filed under: Palliative Care | Tags: , |

NICE publishes new end of life care quality standard – 30 November 2011

“Around half a million people die each year in England and the issues considered to be important at this time can differ enormously from one person to another. Preparation for death, communication with carers and physicians that is sensitive and responsive, and being treated with dignity and respect are often deemed significant.

This new quality standard includes 16 statements for the care of adults (18 years and older) with advanced, progressive, or incurable conditions who are approaching the end of their life and are expected to die within the next 12 months. The end of life definition also includes adults with existing conditions who are at risk of dying from a sudden, acute crisis in their condition, or those with life-threatening acute conditions caused by sudden catastrophic events. The standard also covers support for the families and carers of such people.

The quality standard statements include:”

… continues on the site

Read Full Post | Make a Comment ( Comments Off on NICE publishes new end of life care quality standard – 30 November 2011 )

Prevention and control of healthcare-associated infections quality improvement guide – NICE – 9 November 2011

Posted on November 14, 2011. Filed under: Infection Control, Patient Safety | Tags: |

Prevention and control of healthcare-associated infections quality improvement guide – NICE – 9 November 2011

“Following a referral from the Department of Health, the National Institute for Health and Clinical Excellence (NICE), in partnership with the Health Protection Agency (HPA), have developed this quality improvement guide. The guide offers advice on management or organisational actions to prevent and control healthcare-associated infections (HCAIs) in secondary care settings.

The guide is aimed at board members working in (or with) secondary care. It may also be of use to senior managers, those working elsewhere in the NHS, as well as those working in local authorities and the wider public, private, voluntary and community sectors.

In producing this guide, NICE and the HPA have assumed that all secondary care settings are compliant with the current code of practice on preventing and controlling infections[1].

The guide aims to help build on advice given in the code and elsewhere to improve the quality of care and practice in these areas over and above current standards. Taken together, the quality improvement statements contained in this guide describe excellence in care and practice to prevent and control HCAIs. Examples of evidence and other data to demonstrate progress against each statement are provided.

NICE and the HPA recognise that a range of factors associated with infection prevention and control have the potential to impact on health inequalities (for example, in relation to age, ethnicity, gender and disability). However, the relative impact of different factors will vary for different organisations. NICE and the HPA expect trusts and other secondary care organisations to consider local issues in relation to health inequalities when implementing this guide.”

… continues on the site

HPA commentary

Read Full Post | Make a Comment ( Comments Off on Prevention and control of healthcare-associated infections quality improvement guide – NICE – 9 November 2011 )

Common mental health disorders: identification and pathways to care – NICE – 26 May 2011

Posted on May 31, 2011. Filed under: Mental Health Psychi Psychol, Primary Hlth Care | Tags: |

Common mental health disorders: identification and pathways to care – NICE – 26 May 2011

“Description
This clinical guideline offers evidence-based advice on the care and treatment of adults who have common mental health disorders, with a particular focus on primary care. It brings together advice from existing guidelines and combines it with new recommendations on access to care, assessment and developing local care pathways for common mental health disorders. Common mental health disorders include depression, generalised anxiety disorder, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder and social anxiety disorder.”

About the guidance

Read Full Post | Make a Comment ( None so far )

NICE Pathways – launched 10 May 2011

Posted on May 10, 2011. Filed under: Evidence Based Practice | Tags: , |

New online tool brings all related NICE guidance together for first time – 10 May 2011

“Today (Tuesday 10 May), the National Institute for Health and Clinical Excellence (NICE) has launched NICE Pathways at its annual conference in Birmingham. An online tool for health and social care professionals, NICE Pathways brings together all connected NICE guidance on a topic in a user-friendly electronic flowchart.

Previously there has been no easy way to see at a glance everything NICE has said on a specific condition, for example diabetes, across all its separate published guidance. For the first time ever, this digital resource will allow users to quickly view and navigate NICE guidance and other tools on any given topic across an entire care pathway. For example, the postnatal care pathway considers everything from the baby’s first 24 hours up until the first 2 – 8 weeks.

The 18 pathways launched today cover alcohol-use disorders, anaemia management in chronic kidney disease, breast cancer, chronic heart failure, chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), dementia, depression, diabetes, diabetes in pregnancy, diet, glaucoma, neonatal jaundice, physical activity, postnatal care, smoking, stroke, and venous thromboembolism (VTE) prevention.

Covering the whole range of different types of NICE advice, including health technology appraisals, clinical guidelines, public health and social care advice, quality standards and implementation tools, this is part of a wider move to provide a more personalised, audience-focused way of looking at NICE guidance.

Users do not need to understand how NICE classifies its guidance to read everything NICE has said on a particular topic. They will now be able to easily select the sections of guidance they need. This new resource will also greatly facilitate access to NICE guidance for commissioners, who need to commission care across a whole pathway.

Individual pathways also link to other related pathways – for example the diet pathway links with the physical activity pathway. NICE Pathways will continue to develop by including more content and more topics as new NICE guidance is published and by adding new features such as linking to the evidence behind NICE recommendations.”  … continues

Read Full Post | Make a Comment ( None so far )

NICE publishes process and methods guides for its Medical Technologies Evaluation Programme – 20 April 2011

Posted on April 21, 2011. Filed under: Health Technology Assessment | Tags: |

NICE publishes process and methods guides for its Medical Technologies Evaluation Programme – 20 April 2011

“The National Institute for Health and Clinical Excellence (NICE) has published the process and methods guides for its Medical Technologies Evaluation Programme. This work programme focuses specifically on helping enable new medical technologies, or important modifications to existing ones, to be used more quickly and consistently in the NHS.
The process and methods guides explain how evaluations will work, and will be of particular interest to manufacturers considering notifying their device or diagnostic to the programme. The process is designed so that guidance is developed for the NHS in an open, credible, transparent and timely way allowing appropriate input from relevant stakeholders. NICE consulted on the draft guides during 2010, and received over 500 comments from a range of stakeholders including individuals and organisations within the NHS, the medical technologies industry, academia, patient organisations and the Department of Health. This substantial and valuable input has informed the guides’ development.”

Read Full Post | Make a Comment ( None so far )

Weight management before, during and after pregnancy (CMG36) – NICE – March 2011

Posted on April 19, 2011. Filed under: Obstetrics | Tags: , |

Weight management before, during and after pregnancy (CMG36) – NICE – March 2011

“The Confidential Enquiry into Maternal and Child Health (CEMACH) (2007) highlighted that obesity in pregnancy carries significant risks and identified that over half the women who died either directly or indirectly from pregnancy related causes were overweight or obese[1]. Babies born to obese women also face several health risks including a higher risk of fetal death, stillbirth, congenital abnormality, shoulder dystocia, macrosomia and subsequent obesity[2].

The resulting NHS costs attributable to being overweight and obese are projected to reach £9.7 billion by 2050, with wider costs to society estimated to reach £49.9 billion per year[3]. The NICE costing report for NICE public health guidance PH27 highlights that additional costs are incurred when complications arise in pregnancy, during delivery and following childbirth. Increased risks of complications during pregnancy and after childbirth include impaired glucose tolerance and gestational diabetes, miscarriage, pre-eclampsia, thromboembolism and maternal death[4].

Weight management includes assessing and monitoring body weight, preventing someone from becoming overweight (body mass index [BMI] 25–29.9 kg/m2) or obese (BMI greater than or equal to 30 kg/m2), and helping them to achieve and maintain a healthy weight before, during and after pregnancy by eating healthily and being physically active and gradually losing weight after the baby is born. NICE public health guidance PH27 recommends that pregnant women have their weight and height measured and BMI calculated and recorded at the first contact with the health professional. This is important because obesity will have a greater influence on the pregnant woman’s health and the health of her unborn child than the amount of weight she may gain during pregnancy. Calculating and recording BMI will help with care planning and with the aim of preventing or managing any complications related to obesity. It is also important to commission weight management services to help women lose weight before they become pregnant.”

… continues on the site

Read Full Post | Make a Comment ( None so far )

NICE backs use of new cardiac output monitoring device by the NHS – 29 March 2011

Posted on March 30, 2011. Filed under: Cardiol / Cardiothor Surg, Surgery | Tags: , |

NICE backs use of new cardiac output monitoring device by the NHS

“The National Institute for Health and Clinical Excellence (NICE) has today (Wednesday 30 March) published final guidance which supports the case for adoption of CardioQ-ODM in the NHS. Based on the best available evidence and expert advice, the Institute found this new device offers proven advantages for both patients and the NHS. It advises CardioQ-ODM should be considered for use in patients undergoing major or high-risk surgery, or for other surgical patients who may require invasive cardiovascular monitoring.”  …continues on the site

 CardioQ-ODM (oesophageal Doppler monitor)

Read Full Post | Make a Comment ( None so far )

Chronic kidney disease quality standard – NICE UK – 15 March 2011

Posted on March 18, 2011. Filed under: Nephrology | Tags: |

Chronic kidney disease quality standard – NICE UK – 15 March 2011

Read Full Post | Make a Comment ( None so far )

Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence – NICE Guideline – February 2011

Posted on February 28, 2011. Filed under: Alcohol & Drug Dep. | Tags: , |

Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence – NICE Guideline – February 2011

“This clinical guideline offers evidence-based advice on the diagnosis, assessment and management of harmful drinking and alcohol dependence in adults and in young people aged 10–17 years.”

Read Full Post | Make a Comment ( None so far )

NICE launches online resource for general practice – 21 February 2011

Posted on February 22, 2011. Filed under: General Practice, Health Informatics | Tags: |

NICE launches online resource for general practice – 21 February 2011

“NICE has launched a new section of its website, designed to help staff in general practice get the most out of evidence and guidance provided by NICE.

Specifically created to support the use of evidence-based medicine and public health practice, this online resource offers solutions to enable the uptake of NICE and other national guidance in primary care, and contains a section on how NICE can help GP consortia.

Written with help from GPs, practice managers and practice nurses, it will prove a valuable tool to help to deliver high quality primary care and to improve patient outcomes.

Users can quickly access relevant guidance and information, advice to ensure the practice team is up-to-date, and to further their continuing professional development.

It also includes a range of useful information for general practitioners, such as a quick at-a-glance list of the top 10 NICE guidelines for general practice and summaries of the key points for general practice as NICE publishes new guidance each month.

These pages bring together all the resources that are available from NICE to support the emerging GP commissioning consortia, including links to the NICE quality standards, access to the best evidence to support commissioning, through NHS Evidence, and a range of practical tools and support.

The website has four key sections: NICE for my patients, Using NICE guidance in my practice, My NICE resources, and NICE for GP consortia. Each section is easy to access and read, providing high quality targeted information.”

Read Full Post | Make a Comment ( None so far )

The use of incentives to improve health – NICE Citizens Council meeting – 20 – 22 May 2010

Posted on September 29, 2010. Filed under: Public Hlth & Hlth Promotion | Tags: , |

The use of incentives to improve health – NICE Citizens Council meeting – 20 – 22 May 2010

At its May 2010 meeting, the key question for the Council was as follows:
“In what circumstances are incentives to promote individual behaviour change an acceptable way of promoting the health of the public?”

Read Full Post | Make a Comment ( None so far )

A model for service provision for pregnant women with complex social factors – NICE – 22 September 2010

Posted on September 23, 2010. Filed under: Obstetrics, Social Work | Tags: , |

A model for service provision for pregnant women with complex social factors – NICE – 22 September 2010

Description
The care that women should be offered during pregnancy is outlined in NICE clinical guideline 62 (‘Antenatal care’). However, pregnant women with complex social factors may need additional support to use antenatal care services.

About this guidance
Clinical guidelines CG110
Issued: September 2010

Media release

Read Full Post | Make a Comment ( None so far )

Delirium: diagnosis, prevention and management – NICE – 28 July 2010

Posted on August 12, 2010. Filed under: Aged Care / Geriatrics | Tags: , , |

Delirium: diagnosis, prevention and management – NICE – 28 July 2010

Press release:  New NICE guideline set to encourage healthcare professionals to ‘think delirium’ and take steps to prevent it

From the press release:  “Individual care by a trained multidisciplinary team can help prevent delirium for those people identified at risk, according to new guidelines published today (28 July). The National Institute for Health and Clinical Excellence (NICE) also recommends health professionals should ‘think delirium’ whenever people are admitted to hospital or long-term care.

This new clinical guideline describes methods of preventing, identifying, diagnosing and managing delirium. In particular, the guideline focuses on preventing delirium in people identified to be at risk, using a targeted, multi-component, drug-free intervention that is tailored for each individual.

Delirium is a recent and usually fluctuating change in a person’s awareness, often shown as disorientation or confusion, or through difficulties with memory. It can often be triggered by an infection, operation or a new drug. It can affect up to 1 in 3 hospital patients in the UK, but is potentially preventable in about a third of these cases. Delirium can lead to longer stays in hospital, bed pressure sores, and may increase the risks of dementia and death. However, the condition is poorly recognised in UK hospitals and long-term care, and preventative methods are generally not in place.

Preventing delirium in people at risk during their admission to hospital is anticipated to bring cost savings and release resources to the NHS. This is through a reduction in bed stay and a reduction in hospital-acquired complications. The NICE guideline is based on the best available evidence and will provide doctors, nurses and care assistants with a gold standard for effective treatment.”

Read Full Post | Make a Comment ( None so far )

Motor neurone disease – non-invasive ventilation – NICE Guidance – July 2010

Posted on August 12, 2010. Filed under: Neurology, Respiratory Medicine | Tags: , |

Motor neurone disease – non-invasive ventilation – NICE Guidance – July 2010

The use of non-invasive ventilation in the management of motor neurone disease

Description

This clinical guideline offers evidence-based advice on the use of non-invasive ventilation for people with motor neurone disease. It is the full guideline and contains all the recommendations, details of how they were developed, and reviews of the evidence they were based on.

Read Full Post | Make a Comment ( None so far )

Democracy, deliberation and public service reform. The case of NICE – The 2020 Public Services Trust at the RSA – 2010

Posted on August 5, 2010. Filed under: Health Mgmt Policy Planning, Health Systems Improvement | Tags: |

Democracy, deliberation and public service reform. The case of NICE – The 2020 Public Services Trust at the RSA – 2010

Annabelle Lever, ESRC Economic & Social Research Council
ISBN 978-1-907815-11-9

Extract
“In this enjoyable and challenging paper, Dr Annabelle Lever reminds us that engaging the public in a meaningful way is neither straightforward nor without its own underlying issues. Her analysis of NICE’s experience of lay deliberation over the cost-effectiveness of NHS treatments demonstrates the validity and strength of ‘deliberative solutions to seemingly technical problems’. But it also uncovers challenges. Deliberation and consultation are expensive; they are vulnerable to information asymmetries; and an objective presentation of the evidence being considered is difficult to achieve.”

Read Full Post | Make a Comment ( None so far )

Using NICE guidance to help you cut costs

Posted on July 30, 2010. Filed under: Health Economics | Tags: , |

Using NICE guidance to help you cut costs 

“Is it possible to increase the quality of care provided against a backdrop of tightening budgets? We think it is, and that NICE has a key role to play. From identifying specific recommendations that can save money, to advice on reconfiguring to support disinvestment from ineffective services, we have products and services to help organisations meet the twin challenges of providing high quality care to patients and the public while also saving money and resources.”

 How NICE could help the NHS save millions 

“The NHS could stand to save millions – at a time when healthcare budgets are being squeezed – by following NICE guidance, according to a review by the Institute.   …

NICE has identified 19 sets of recommendations that if fully implemented by trusts could help to save millions of pounds. This list is based on costing work undertaken at the time the guidance is published and covers all clinical guidelines from January 2005 and technology appraisals from January 2006 that deliver a net saving.  …

All of NICE’s cost-saving tools and information can be found here

Read Full Post | Make a Comment ( None so far )

NICE publishes final draft guidance on the use of dronedarone for treating atrial fibrillation – 16 July 2010

Posted on July 27, 2010. Filed under: Cardiol / Cardiothor Surg | Tags: , |

NICE publishes final draft guidance on the use of dronedarone for treating atrial fibrillation – 16 July 2010

“The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of dronedarone (Multaq) for the treatment of atrial fibrillation (AF) – a disturbance of the heart’s rhythm. In its final draft guidance published today, (16 July), NICE has reaffirmed the decision in its previous draft to recommend the limited use of the drug as a second-line treatment in people with additional cardiovascular risk factors whose AF has not been controlled by first-line therapy.

Sir Andrew Dillon, NICE Chief Executive, said: “The independent Appraisal Committee concluded that although dronedarone reduced atrial fibrillation recurrence compared with placebo, it appeared to be less effective for atrial fibrillation recurrence than other antiarrhythmic drugs. However, it noted comments from patients and clinical experts received during consultation on a previous draft that all current antiarrhythmic drugs have side effects that have a significant impact on quality of life with long-term use. It heard from patient experts that some people with atrial fibrillation might prefer to take dronedarone because it has fewer side effects, despite it being less effective in preventing recurrence of atrial fibrillation.

He continued: “The Committee also accepted evidence that the risk of mortality with dronedarone was likely to be lower than with current anti-arrhythmic drugs. Finally, because the cost-effectiveness estimates for the drug were largely based on a single clinical trial, which included people who had a higher risk of a major cardiovascular event, we have recommended that dronedarone is considered as a treatment option only in people who have additional cardiovascular risk factors such as diabetes or high blood pressure.”

In line with the NICE technology appraisals process this draft guidance is now with consultees, who have the opportunity to appeal against the proposed guidance. NICE has not yet issued final guidance to the NHS. Final guidance is expected to be published in August 2010.  …continues

Read Full Post | Make a Comment ( None so far )

NICE – SeQuent Please balloon catheter for in-stent coronary restenosis: medical technologies consultation – July 2010

Posted on July 27, 2010. Filed under: Cardiol / Cardiothor Surg, Health Technology Assessment | Tags: |

NICE’s medical technologies programme issues first draft guidance

“The first piece of guidance has been published from NICE’s new medical technologies programme, set up to help the NHS adopt efficient and cost effective medical devices and diagnostics more rapidly and consistently.

The draft guidance recommends the use of a balloon catheter, SeQuent Please, for patients who have suffered restenosis, a condition where the blood vessels become blocked again following a previous treatment with a stent.

The Evaluation Pathway Programme for Medical Technologies was established in November 2009 to focus specifically on the evaluation of innovative medical technologies. Its purpose is to produce guidance on the use of devices and diagnostics to speed up the introduction into the health service of those products offering significant benefits, or helping technologies to be investigated more thoroughly in research.

The types of products that are assessed under the new programme are medical devices that deliver treatment such as those implanted during surgical procedures, technologies that give greater independence to patients, and diagnostic devices or tests used to detect or monitor medical conditions.

An independent group of experts, the Medical Technologies Advisory Committee (MTAC), is responsible for deciding which medical technologies should be selected for evaluation, as well as developing the guidance itself.”  … continues

Read Full Post | Make a Comment ( None so far )

Using NICE guidance to help you cut costs

Posted on July 27, 2010. Filed under: Clin Governance / Risk Mgmt / Quality, Health Systems Improvement | Tags: , |

Using NICE guidance to help you cut costs 

“Is it possible to increase the quality of care provided against a backdrop of tightening budgets? We think it is, and that NICE has a key role to play. From identifying specific recommendations that can save money, to advice on reconfiguring to support disinvestment from ineffective services, we have products and services to help organisations meet the twin challenges of providing high quality care to patients and the public while also saving money and resources.”

 How NICE could help the NHS save millions 

“The NHS could stand to save millions – at a time when healthcare budgets are being squeezed – by following NICE guidance, according to a review by the Institute.

Implementing NICE guidance can provide a way for primary care trusts (PCTs) in England to ensure that patients receive treatment that is proven to be both clinically and cost effective. Following NICE guidance can also free up resources and capacity that can then be channeled into other services. …

NICE has identified 19 sets of recommendations that if fully implemented by trusts could help to save millions of pounds. This list is based on costing work undertaken at the time the guidance is published and covers all clinical guidelines from January 2005 and technology appraisals from January 2006 that deliver a net saving.  …

All of NICE’s cost-saving tools and information can be found here

Read Full Post | Make a Comment ( None so far )

Metastatic malignant disease of unknown primary origin – NICE guideline – 26 July 2010

Posted on July 27, 2010. Filed under: Oncology | Tags: |

NICE guideline set to transform cancer care for thousands of patients 

Media release:
“From today (26 July), specialist cancer teams will be tasked with improving the care and treatment of patients whose cancer has spread to other parts of the body from an unknown primary location. The re-organisation of cancer services for this group of patients is one of a raft of measures being recommended by the National Institute for Health and Clinical Excellence (NICE) to tackle the current inequality in care these patients often receive compared with people who have a site-specific type of cancer such as breast, lung or prostate.

This guideline has received the support of the National Cancer Peer Review Programme in England, which is studying the recommendations to develop a number of peer review measures. These are ‘quality measures’ that hospitals are required to follow and are assessed against with the aim of improving care for cancer patients and their families.”

…continues

The Guideline:
Metastatic malignant disease of unknown primary origin: Diagnosis and management of metastatic malignant disease of unknown primary origin

“Description
The advice in the NICE guideline covers: the treatment and care of adults with suspected or diagnosed cancer of unknown primary, including people who have been treated for cancer before.”

Read Full Post | Make a Comment ( None so far )

NICE launches quality standards for the NHS – 1 July 2010

Posted on July 2, 2010. Filed under: Clin Governance / Risk Mgmt / Quality | Tags: , |

NICE launches quality standards for the NHS – 1 July 2010

NICE has unveiled the first set of quality standards, setting out a vision of what high-quality care should look like for patients on the NHS.

Some 150 clinical areas will eventually have their own set of quality standards, with the first three standards published yesterday covering the treatment and care of stroke, dementia and venous-thromboembolism (VTE) prevention.

The new quality standards are a series of concise statements that show what high-quality care should look like for these conditions, and are sourced from the best available evidence such as NICE guidance, or evidence accredited by NHS Evidence.”

…continues

Read Full Post | Make a Comment ( None so far )

NICE guideline on blood clot prevention – 27 January 2010

Posted on January 28, 2010. Filed under: Surgery | Tags: , , , |

2010/006 New NICE guideline on blood clot prevention will help save thousands of lives

“Thousands of lives could be saved with the help of a new guideline on preventing blood clots in hospital patients, published today (Wednesday 27 January) by the National Institute for Health and Clinical Excellence (NICE).  The guideline focuses on reducing the risk of deep vein thrombosis (blood clots blocking veins, also commonly known as DVT) in patients admitted to hospital.  If a blood clot breaks away it may travel to the lungs and cause a blockage – a potentially fatal pulmonary embolism.   Venous thromboembolism (VTE) covers both DVT and its possible consequence pulmonary embolism – the guideline sets out simple steps to help prevent VTE and therefore help save lives.

An estimated 25,000 people who are admitted to hospital die from preventable venous thromboembolism each year.  The NICE guideline, jointly developed with the National Clinical Guideline Centre for Acute and Chronic Conditions, recommends that all patients should be assessed for risk of developing blood clots on admission to hospital, and then given preventative treatment that suits their individual needs. Options include blood-thinning drugs such as heparin, anti-embolism stockings and foot impulse or pneumatic devices.  Importantly, this advice covers all patients admitted to hospital – including those having day-case procedures – and not just those patients having surgery.”

See the NICE VTE guideline

Read Full Post | Make a Comment ( None so far )

NICE publishes draft recommendations on the management of chronic heart failure in adults – 14 January 2010

Posted on January 15, 2010. Filed under: Cardiol / Cardiothor Surg | Tags: |

 

NICE publishes draft recommendations on the management of chronic heart failure in adults

“NICE is in the process of updating its clinical guideline on the management of chronic heart failure in adults and has today (14 January) published its draft recommendations for public consultation.Since the original guideline was published in 2003, new high-quality evidence from randomised controlled trials in diagnosis, treatment and monitoring have been published. This partial update will ensure that the recommendations take into account the new evidence available.

Heart failure is a complex clinical syndrome of symptoms and signs such as breathlessness, fatigue and fluid retention  that suggest the efficiency of the heart is impaired. The most common cause of heart failure in the UK is coronary artery disease, with many patients having suffered a myocardial infarction (heart attack) in the past. The draft recommendations cover the diagnosis and treatment of heart failure, including defining the combination of symptoms, signs and investigations which together are most effective in confirming a diagnosis of heart failure and influencing subsequent optimum treatments.

Dr Fergus Macbeth, Director, Centre for Clinical Practice at NICE said: “The prevalence of heart failure is expected to rise in the future as more people live longer generally, people survive longer with coronary artery disease and there are better treatments for heart failure. Currently some 900,000 people in the UK have had a diagnosis of heart failure, with almost as many again who may have damaged hearts but as yet no symptoms. It’s clearly very important that clinicians working in this area have a guideline that is based on the most up-to-date evidence of what works best. This new draft guideline outlines a comprehensive approach to the management of heart failure, and  ultimately seeks to improve the length and quality of life of people with the condition.

Dr Macbeth continued:“The draft guideline clearly indicates those recommendations that are new or have been changed from the original. For example, the original guideline recommended the use of echocardiography to help confirm a diagnosis of heart failure only after other tests were inconclusive. However, based on a review of new evidence about the best way for primary care physicians to diagnose heart failure published since the original NICE guideline, the updated draft recommends that people with suspected heart failure and who have had a previous heart attack should be referred urgently for echocardiography and specialist assessment.”

The draft recommendations are available on the NICE website.  ”

NICE publishes draft recommendations on the management of chronic heart failure in adults
14 January 2010  (36.14 Kb 10 sec @ 28.8Kbps)

Read Full Post | Make a Comment ( None so far )

CoCanCPG Database of Cancer Uncertainties (DoCU)

Posted on December 10, 2009. Filed under: Oncology | Tags: , , |

CoCanCPG Database of Cancer Uncertainties (DoCU)  –  About this new database – from NICE

The database

“Project background
CoCanCPG (Coordination of Cancer Clinical Practice Guidelines in Europe) is a European Commission funded consortium of 16 institutional partners from 11 countries. The UK’s National Institute of Health and Clinical Excellence (NICE), working with the consortium, has developed this database of cancer uncertainties (DoCU) in the management of cancer that have been identified during guideline development.

Development of the database
The overall objective of the project is to set up, within CoCanCPG, a framework and database for systematically identifying evidence gaps and formulating and prioritising recommendations for future research in cancer. These evidence gaps or ‘uncertainties’ can be highlighted during guideline development (including systematic reviews and economic modelling) or post-production (exploring the research recommendations and other standalone uncertainties in cancer management in the guidance). Further details about identifying uncertainties and processing them can be found in the ‘Collecting Uncertainties’ page.

The database is a developmental project, which is being tested in this pilot phase. The pilot period ends at the end of January 2010.

The database is funded by the EU and hosted and administered by NICE.”

View the list of uncertainties flagged as a priority

Search the database

Read Full Post | Make a Comment ( None so far )

NICE starts work on setting quality standards – 29 July 2009

Posted on July 30, 2009. Filed under: Clin Governance / Risk Mgmt / Quality | Tags: , |

NICE starts work on setting quality standards

“The National Institute for Health and Clinical Excellence (NICE) welcomes the referral of four clinical areas by the Department of Health following advice from the National Quality Board and will now begin work on setting NICE quality standards for the NHS using a pilot process.

The Darzi report, High Quality Care For All (June 2008), expanded NICE’s role to include setting and approving more independent quality standards for the NHS. The report highlighted the difficulties clinicians faced in keeping up with the best evidence. It stated that standards should clarify what high quality care looks like with regard to:

* clinical effectiveness
* patient safety
* patient experience.

This work is a key part of making quality the organising principle of the NHS and supporting the drive to improve standards of care.”  … continues on the website

Read Full Post | Make a Comment ( None so far )

Reaching out – community engagement and health – UK – July 2009

Posted on July 28, 2009. Filed under: Community Services, Patient Participation, Public Hlth & Hlth Promotion | Tags: |

Reaching out – community engagement and health – the report

Information that follows copied fromNHS Networks News

“Building on NICE guidance on community engagement and health

This is the third in a series of publications from the IDeA’s Healthy Communities programme, this time written in conjunction with NICE (National Institute for Health and Clinical Excellence). The document explores the importance of engaging communities in health promotion and health services, and the health benefits that this can bring.

It builds on the NICE guidance on community engagement and health published earlier this year. It reflects recent government commitments to engaging the public further in democratic and decision-making processes. These are outlined in the Community Empowerment White Paper, ‘Communities in Control’.

The publication is designed to stimulate thinking about community engagement in any council. It is particular relevant to those working in patient and public involvement. It should also interest community development officers, lead members for health and public health workers.”

Read Full Post | Make a Comment ( None so far )

Kennedy study of valuing innovation – UK – 22 July 2009

Posted on July 23, 2009. Filed under: Health Technology Assessment | Tags: , , |

Kennedy study of valuing innovation – UK – 22 July 2009

Sir Ian Kennedy presents his report on the value of new innovative health technologies – Press release

From the press release:
“In February 2009, NICE asked Professor Sir Ian Kennedy to undertake an independent study in response to the views expressed by Sir David Cooksey in his Review and Refresh of Bioscience 2015.

Sir Ian Kennedy was asked to carry out a short study on how NICE establishes the value of innovation, and in particular to make recommendations about what approach should be adopted by NICE to ensure that innovation is properly taken into account when establishing the value of new health technologies. In undertaking the study, Sir Ian Kennedy called for submissions from interested parties, and held a series of workshops to explore the issues with individuals from the healthcare industries, healthcare professionals, the NHS, patients and the wider public. Sir Ian Kennedy’s study was also informed by the views of NICE’s Citizens Council, who considered innovation at its meeting in May 2009.

Sir Ian Kennedy presented his report at the public NICE Board meeting on the 22 July 2009. The report and further information about the study is available on the NICE website.

Professor Sir Michael Rawlins said: “We are very grateful to Sir Ian for his report on the value of innovation, and for broad confidence he has expressed in NICE and its methods. Since NICE was established we have regularly consulted on our approach to valuing the benefits of new technologies and we welcome the opportunity to focus on innovation. Sir Ian’s report raises a number of issues that NICE will need to consider. NICE’s Board will set out a formal response at its next public Board meeting in September, which will then be the subject of a three-month consultation.”

Read Full Post | Make a Comment ( None so far )

Comparative Effectiveness Review Within the U.K.’s National Institute for Health and Clinical Excellence – The Commonwealth Fund – 22 July 2009

Posted on July 23, 2009. Filed under: Clin Governance / Risk Mgmt / Quality | Tags: , , |

K. Chalkidou, Comparative Effectiveness Review Within the U.K.’s National Institute for Health and Clinical Excellence, The Commonwealth Fund, 22 July 2009.

Overview

“The U.K.’s National Institute for Health and Clinical Excellence (NICE) was established to perform three core functions: 1) reduce unwarranted variation in practice across the United Kingdom through the development and dissemination of best practice evidence-based standards; 2) encourage fast diffusion and uniform uptake of high-value medical innovations; and 3) ensure the taxpayers’ money is invested in the National Health Service so that health benefit is maximized. NICE decisions are made by independent committees of health professionals, academics, and industry and lay representatives. More than 2,000 experts engage with NICE processes throughout the year. NICE committees consider comparative clinical and cost effectiveness, social values (including impact on equity), and U.K. and European Union legislation when making their decisions.”

Read Full Post | Make a Comment ( None so far )

The (UK) Government’s Response to the Health Select Committee Report on Top-up fees (for drugs) – Presented to Parliament by the Secretary of State for Health by Command of Her Majesty July 2009

Posted on July 8, 2009. Filed under: Health Economics, Pharmacy | Tags: , , |

The (UK) Government’s Response to the Health Select Committee Report on Top-up fees (for drugs) – Presented to Parliament by the Secretary of State for Health by Command of Her Majesty July 2009

Cm 7649   ISBN: 978 0 10 176492 6

“1. The House of Commons Health Select Committee published its report on “Top-Up fees” on Tuesday 12 May 2009. This Command Paper sets out the Government’s response to the conclusions and recommendations of that report. We are very grateful for the attention and insight that the Committee has brought to this important and complex issue.

2. On 17 June 2008, the Secretary of State for Health asked Professor Mike Richards, the National Clinical Director for Cancer, to review the policy for patients who wished to buy additional drugs privately. During the course of the review, Professor Richards spoke to over 2,000 patients, members of the public, NHS staff, NHS managers and other stakeholders.”  … continues on the website

Read Full Post | Make a Comment ( None so far )

NICE issues final guidance on the use of cetuximab for the treatment of head and neck cancer – 24 June 2009

Posted on June 25, 2009. Filed under: Oncology | Tags: , |

2009/040 NICE issues final guidance on the use of cetuximab for the treatment of head and neck cancer

Press release

Guidance

“The National Institute for Health and Clinical Excellence (NICE) has today (24 June) published guidance on cetuximab for the treatment of recurrent and/or metastatic (where the cancer has spread) squamous cell cancer of the head and neck. The guidance does not recommend cetuximab in combination with platinum- based chemotherapy as a treatment option for patients with this type of head and neck cancer.”

Read Full Post | Make a Comment ( None so far )

NICE short clinical guideline increases treatment options for patients with type 2 diabetes – 27 May 2009

Posted on May 27, 2009. Filed under: Diabetes | Tags: |

2009/033 NICE short clinical guideline increases treatment options for patients with type 2 diabetes

“The National Institute for Health and Clinical Excellence (NICE) have today (27 May 2008) issued guidance on the use of newer agents for blood glucose control in adults with type 2 diabetes. The new short clinical guideline is a partial update of last year’s clinical guideline “Type 2 Diabetes (Update)” and examines several new and existing treatments for the management of blood glucose levels in individuals with type 2 diabetes.

The management of blood glucose levels, reflected in a patient’s value of haemoglobin HbA1c , is a central part of diabetes treatment. The NICE guidance recommends a number of new treatments to help manage levels of blood glucose, positioning these treatments among existing therapies for type 2 diabetes.  These include recommendations on the use of long-acting insulin analogues, inhibitors of dipeptidylpeptidase-4 (DPP-4 inhibitors), glucagon-like peptide-1 (GLP-1) mimetics and thiazolidinediones within their licensed recommendations.”

2009/033 NICE short clinical guideline increases treatment options for patients with type 2 diabetes (38 Kb 11 sec @ 28.8Kbps)

Read Full Post | Make a Comment ( None so far )

NICE guideline to improve the recognition and assessment of coeliac disease – 27 May 2009

Posted on May 27, 2009. Filed under: Gastroenterology | Tags: , |

2009/032 NICE guideline to improve the recognition and assessment of coeliac disease

“The National Institute for Health and Clinical Excellence (NICE) has today (27 May 2009) issued a guideline to improve the recognition and diagnosis of coeliac disease. Coeliac disease is a condition in which the immune system in a person’s intestine (gut) reacts to a protein called gluten. The immune reaction makes part of the gut inflamed, which can make it difficult for the person to absorb nutrients from their food. Coeliac disease can cause a wide range of symptoms in the digestive system (such as indigestion, diarrhoea or constipation) and in the rest of the body (such as tiredness, weight loss and bone thinning).”  … continues on the website

Full text of the guideline (36.83 Kb 10 sec @ 28.8Kbps)

Read Full Post | Make a Comment ( None so far )

New NICE guidelines to help millions of people with low back pain – 27 May 2009

Posted on May 27, 2009. Filed under: Orthopaedics, Physiotherapy | Tags: , |

2009/031 New NICE guidelines to help millions of people with low back pain

“Millions of people with low back pain will benefit from new guidance issued to the NHS on the most effective ways to treat this often painful and distressing condition.

The National Institute for Health and Clinical Excellence (NICE) and the National Clinical Guideline Centre today (Wednesday 27 May) publish a guideline to improve the early management of persistent non-specific low back pain.  This covers people who have been in pain longer than six weeks but less than one year, where the pain may be linked to structures in the back such as the joints, muscles and ligaments.  Setting out a range of effective mainstream and complementary treatments, the guideline recommends what care and advice the NHS should offer to people affected by low back pain.” … continues on the website

Full text of the low back pain guideline (36.35 Kb 10 sec @ 28.8Kbps)

Read Full Post | Make a Comment ( None so far )

NICE contributes to the Health Select Committee inquiry on Alcohol – May 2009

Posted on May 22, 2009. Filed under: Alcohol & Drug Dep. | Tags: |

NICE contributes to the Health Select Committee inquiry on Alcohol

“What is the scale of ill-health related to alcohol misuse, and what are the consequences for the NHS? To address alcohol-related health problems, should the drinking culture in England change, and if so, how? These questions form part of the terms of reference for the House of Commons Health Select Committee (HSC), which is currently holding an inquiry on alcohol and its impact on health. The HSC is a group of cross-party MPs who examine a range of health matters, inviting experts from the public, private and voluntary sectors to give their views on the matter in question. Their resulting report advises government on what actions should be taken.

Professor Mike Kelly, NICE Director of the Centre for Public Health Excellence, was one of three witnesses invited to give evidence at a recent HSC session on what steps should be considered to tackle the rising problem of alcohol misuse. This inquiry is particularly timely, as NICE is currently producing guidance in both its public health and clinical programmes addressing alcohol misuse: prevention of alcohol misuse, clinical management of alcohol disorders, and alcohol dependence and harmful alcohol use.

In response to a Committee query about what more could be done to prevent development of alcohol related problems, Professor Kelly advised that an important step is for the NHS to recognise alcohol as a major priority. He also highlighted that alcohol use can change over time: “Trends in alcohol use are not an unstoppable juggernaut that can’t be turned around. Patterns have changed over the last 20 to 30 years: having a drink at lunchtime was fairly common but in many sectors that has now stopped. However, a pattern for some people of drinking more in the evenings and at weekends exists, which needs to be addressed. There is a good evidence base for what works to tackle alcohol misuse, but these approaches need to be integrated into the way that people live – taking account of how people work and spend their leisure time.”

Questions from the committee on the three best interventions that the NHS should focus on drew a range of responses from the three witnesses, including more screening, more alcohol health workers and more joined-up government action. One point was noted by Professor Kelly as often being overlooked, given the many binge-drinking stories that have become so familiar: “Alcohol is a population-based problem. If the NHS focuses solely at the binge-drinking or problematic-drinking end of the spectrum, an opportunity will be missed to reduce consumption of alcohol across the general population. A national strategy is needed so that the people who consider themselves to be sensible drinkers – but who may actually be drinking potentially harmful amounts – are also targeted as that’s where problems build.”

The NICE public consultation on the evidence for the alcohol-use: Prevention guidance is open until June 17, with final guidance scheduled for publication in spring 2010.

Read Full Post | Make a Comment ( None so far )

NHS Evidence has been launched

Posted on May 1, 2009. Filed under: Evidence Based Practice, Knowledge Translation | Tags: , , |

Press release on the launch of NHS Evidence

from the website about    NHS Evidence:

“Background to NHS Evidence

The creation of NHS Evidence was announced on June 30th 2008 as part of the High Quality Care for All report from Lord Darzi, who stated that: “All NHS Staff will have access to a new NHS Evidence service where they will be able to get, through a single web-based portal, authoritative clinical and non-clinical evidence and best practices.”

The NHS Evidence service

The principle aim of the NHS Evidence service is to provide easy access to a comprehensive evidence base for everyone in health and social care who takes decisions about treatments or the use of resources – including clinicians, public health professionals, commissioners and service managers – thus improving health and patient care. It will build on NICE’s significant international reputation for developing high quality evidence-based guidance. It provides access to a range of information types, including primary research literature, practical implementation tools, guidelines and policy documents.

To achieve the aim stated above, NHS Evidence will:

* Provide comprehensive access to information in health and social care via a web-based portal
* Commission the development of evidence-based information from external agencies, in line with user needs and priorities
* Provide a central purchasing function to enable health professionals in the NHS to access journals and other relevant resources
* Provide a formal accreditation scheme for defined categories of information such as clinical guidelines
* Identify evidence reflecting best practice in particular topic areas to inform a range of user groups
* Engage with users and stakeholders to support the use of evidence in decision-making, and to provide feedback to develop the service”

…. continues on the website

NICE has had a website revamp as well

Read Full Post | Make a Comment ( None so far )

NICE improves rehabilitation for people after critical illness UK National Institute for Health and Clinical Excellence

Posted on April 29, 2009. Filed under: Rehabilitation | Tags: , |

2009/025 NICE improves rehabilitation for people after critical illness UK National Institute for Health and Clinical Excellence

NICE guidance published today (25 March 2009) sets out to improve the quality of care patients receive during their recovery and rehabilitation after critical illness
.

Approximately 110,000 [1] people spend time in critical care units in England and Wales each year, the majority survive to be discharged home. For many patients recovery after critical illness is relatively straightforward but for others, discharge from critical care is the start of an uncertain journey to recovery characterised by problems such as, weakness, loss of energy and physical difficulties, anxiety, depression, post-traumatic stress (PTS) phenomena and, for some, a loss of mental faculty. Family members become informal caregivers, and this itself can exert an additional toll of ill-health and a strain on family relationships and financial security.

This guideline outlines the assessments and care patients should receive in hospital following a critical illness and the rehabilitation goals that will help patients recover to take part in usual daily activities as much and as rapidly as possible following discharge.

Read Full Post | Make a Comment ( None so far )

Rheumatoid arthritis – new NICE guidance February 2009

Posted on April 16, 2009. Filed under: Rheumatology | Tags: , |

Rheumatoid arthritis: the management of rheumatoid arthritis in adults
Guidance type:  Clinical guideline
Date issued:  February 2009

Summary

Rheumatoid arthritis is a long-term disease in which joints in the body become inflamed, causing pain, swelling and stiffness. It is known as an ‘autoimmune disease’ because it is caused when the body’s immune system, which normally fights infection, starts to attack healthy joints. At times, rheumatoid arthritis can be very painful and affect a person’s ability to carry out everyday tasks. It is not known why rheumatoid arthritis develops, and there is no cure. However, understanding of the disease has improved, and there are now effective treatments that can help ease the pain and symptoms, and slow down the disease. It is very important that treatment is started early to minimise damage to joints.

The advice in the NICE guideline covers the care of adults with rheumatoid arthritis. It does not specifically look at other types of arthritis such as osteoarthritis. NICE has also produced guidance on osteoarthritis.

Read Full Post | Make a Comment ( None so far )

New NICE Guidance on Advanced Breast Cancer

Posted on April 16, 2009. Filed under: Oncology | Tags: , , |

The National Institute for Health and Clinical Excellence (NICE) has today (25 February 2009) issued a new guideline on best practice for the diagnosis and treatment of advanced breast cancer.

Read Full Post | Make a Comment ( None so far )

New NICE guidelines on the treatment and care of people with early breast cancer

Posted on April 16, 2009. Filed under: Oncology | Tags: , , |

New NICE guidelines on the treatment and care of people with early breast cancer

The National Institute for Health and Clinical Excellence (NICE) has today (25 February 2009 ) issued a new guideline on best practice for the diagnosis and treatment of early and locally advanced breast cancer.

Read Full Post | Make a Comment ( None so far )

Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence

Posted on April 8, 2009. Filed under: Medications, Patient Participation | Tags: , |

This guidance is about enabling patients to make informed choices by involving and supporting them in decisions about prescribed medicines. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence) to the NHS in England and Wales.   January 2009

Read Full Post | Make a Comment ( None so far )

Promoting physical activity for children – UK National Institute for Health and Clinical Excellence

Posted on April 8, 2009. Filed under: Public Hlth & Hlth Promotion | Tags: |

The National Institute for Health and Clinical Excellence (NICE)  ) issues guidance on promoting physical activity, active play and sport for all children and young people up to the age of 18 in family, pre-school, school and community settings 28 January 2009

Read Full Post | Make a Comment ( None so far )

New NICE guidelines set to improve treatment and management of people with borderline personality disorder – UK National Institute for Health and Clinical Excellence

Posted on April 8, 2009. Filed under: Mental Health Psychi Psychol | Tags: |

NICE guidance published 28 January 2009  outlines how healthcare professionals can identify, treat and manage people with borderline personality disorder.

Read Full Post | Make a Comment ( None so far )

New NICE guidelines set to improve treatment and management of people with antisocial personality disorder – UK National Institute for Health and Clinical Excellence

Posted on April 8, 2009. Filed under: Mental Health Psychi Psychol | Tags: |

NICE guidance published on 28 January 2009 will outline how healthcare professionals can treat, manage and prevent antisocial personality disorder (ASPD).

Read Full Post | Make a Comment ( None so far )

Liked it here?
Why not try sites on the blogroll...